Company intelligence
Jinfiniti Precision Medicine
Targeting your healthspan with actionable biomarkers
Biotechnology Research
Augusta, US
8 employees
Founded 2018
4 public signals
About Jinfiniti Precision Medicine
At Jinfiniti Precision Medicine, we design accurate and precise biomarker tests because we believe each individual should have as much information about their bodies as possible so that they can monitor and improve their well-being in a data-driven way.
Verified activity
Signals from Jinfiniti Precision Medicine
4 published signals
Research & Knowledge
Jinfiniti Precision Medicine published recent research on the mitochondria-synapse axis coordination between energy delivery and synaptic memory encoding.
Reported by Jin-Xiong She, PhD
Research & Knowledge
Jinfiniti Precision Medicine published a 2025 study following 170 older adults grouped as robust, pre-frail, or frail to measure B vitamins, homocysteine, and global DNA methylation.
Reported by Jin-Xiong She, PhD
Research & Knowledge
Jinfiniti Precision Medicine notes that the 2026 ACC/AHA guideline recommends every adult get Lp(a) checked at least once in their lifetime.
Reported by Jin-Xiong She, PhD
Research & Knowledge
Jinfiniti Precision Medicine published a 2026 study following over 10,000 adults showing that adding ApoB to standard risk models improved risk reclassification and was strongest in adults under 40.
Reported by Jin-Xiong She, PhD